VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,800 | -10.7% | 2,000 | 0.0% | 0.02% | -7.4% |
| Q2 2023 | $60,220 | -6.9% | 2,000 | 0.0% | 0.03% | -10.0% |
| Q1 2023 | $64,680 | +12.9% | 2,000 | 0.0% | 0.03% | +11.1% |
| Q4 2022 | $57,300 | +19.4% | 2,000 | 0.0% | 0.03% | +8.0% |
| Q3 2022 | $48,000 | -12.7% | 2,000 | 0.0% | 0.02% | -3.8% |
| Q2 2022 | $55,000 | -28.6% | 2,000 | 0.0% | 0.03% | -21.2% |
| Q1 2022 | $77,000 | +20.3% | 2,000 | 0.0% | 0.03% | +32.0% |
| Q4 2021 | $64,000 | +8.5% | 2,000 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $59,000 | -13.2% | 2,000 | 0.0% | 0.02% | -10.7% |
| Q2 2021 | $68,000 | +4.6% | 2,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $65,000 | -9.7% | 2,000 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $72,000 | -7.7% | 2,000 | 0.0% | 0.03% | -15.4% |
| Q3 2020 | $78,000 | +6.8% | 2,000 | 0.0% | 0.04% | +2.6% |
| Q2 2020 | $73,000 | +143.3% | 2,000 | +53.8% | 0.04% | +111.1% |
| Q1 2020 | $30,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |